文献速递乳腺癌放疗放疗物理与技术

首次人体试验:混合现实可视化用于乳腺癌或胸壁放疗患者摆位

First-in-human trial using mixed-reality visualization for patient setup during breast or chest wall radiotherapy.
PubMed 文献 · Radiat Oncol · 2024-11-18

本研究在质子(n=10)或光子(n=8)乳腺或胸壁放疗患者中开展首次人体试验,比较混合现实(MixR)与三点对齐摆位的可行性。每例患者MixR使用5次、三点对齐使用5次。质子队列平均3D位移三点对齐0.96 cm vs MixR 1.18 cm,光子队列三点对齐1.18 cm vs MixR 1.00 cm,等效性检验提示两种技术配准精度差异分别小于0.5 cm和0.3 cm。结论认为MixR用于乳腺癌放疗摆位在三点对齐所提供的精度和效率水平上是可行的,但需进一步开发标记追踪、反馈并更好理解MixR的感知挑战,以达到与现代表面引导放疗(SGRT)系统相似的精度。

要点

  • 质子队列平均3D位移:三点对齐0.96 cm vs MixR 1.18 cm,等效性检验提示差异小于0.5 cm。
  • 光子队列平均3D位移:三点对齐1.18 cm vs MixR 1.00 cm,等效性检验提示差异小于0.3 cm。
  • 配准时间和图像引导(IGRT)使用量见微小差异;作者认为MixR用于乳腺放疗摆位在三点对齐的精度和效率水平上可行。

核心结论

  • MixR用于乳腺癌放疗患者摆位在三点对齐所提供的精度和效率水平上是可行的。
  • 需进一步开发标记追踪、反馈并更好理解MixR的感知挑战,以达到与现代表面引导放疗(SGRT)系统相似的精度。

研究设计与样本

  • 经IRB批准的首次人体临床试验,纳入接受质子(n=10)或光子(n=8)乳腺或胸壁放疗的患者。
  • 每例患者MixR使用5次,并与另5次三点对齐摆位比较。
  • MixR分次中由至少一名佩戴HoloLens 2设备的治疗师通过同时直接观察患者和基于模拟CT扫描生成的患者体表全息图进行摆位引导。
  • 配准精度用锥形束CT(CBCT,光子)或CBCT加kV/kV成像(质子)量化;全程记录配准时间和最终对齐所用图像引导(IGRT)量。

主要发现

  • 质子队列平均3D位移:三点对齐0.96 cm vs MixR 1.18 cm;等效性检验提示两种技术配准精度差异小于0.5 cm。
  • 光子队列平均3D位移:三点对齐1.18 cm vs MixR 1.00 cm;等效性检验提示两种技术配准精度差异小于0.3 cm。
  • 配准时间和IGRT使用量见微小差异。

局限性

  • 需进一步开发标记追踪、反馈并更好理解MixR的感知挑战,以达到与现代表面引导放疗(SGRT)系统相似的精度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study is to assess the feasibility of mixed-reality (MixR) visualization for patient setup in breast and chest wall radiotherapy (RT) by performing a first-in-human clinical trial comparing MixR with a 3-point alignment. METHODS: IRB approval was granted for a study incorporating MixR during the setup process for patients undergoing proton (n = 10) or photon (n = 8) RT to the breast or chest wall. For each patient, MixR was utilized for five fractions and compared against another five fractions using 3-point alignment. During fractions with MixR, the patient was aligned by at least one therapist wearing a HoloLens 2 device who was able to guide the process by simultaneously and directly viewing the patient and a hologram of the patient's surface derived from their simulation CT scan. Alignment accuracy was quantified with cone-beam CT (CBCT) for photon treatments and CBCT plus kV/kV imaging for proton treatments. Registration time was tracked throughout the setup process as well as the amount of image guidance (IGRT) utilized for final alignment. RESULTS: In the proton cohort, the mean 3D shift was 0.96 cm using 3-point alignment and 1.18 cm using MixR. An equivalence test indicated that the difference in registration accuracy between the two techniques was less than 0.5 cm. In the photon cohort, the mean 3D shift was 1.18 cm using 3-point alignment and 1.00 cm using MixR. An equivalence test indicated that the difference in registration accuracy was less than 0.3 cm. Minor differences were seen in registration time and the amount of IGRT utilization. CONCLUSIONS: MixR for patient setup for breast cancer RT is possible at the level of accuracy and efficiency provided by a 3-point alignment. Further developments in marker tracking, feedback, and a better understanding of the perceptual challenges of MixR are needed to achieve a similar level of accuracy as provided by modern surface-guided radiotherapy (SGRT) systems. TRIAL REGISTRATION: ClinicalTrials.gov, UFHPTI 2015-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization, NCT05178927.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Johnson PB, Bradley J, Lampotang S, et al. First-in-human trial using mixed-reality visualization for patient setup during breast or chest wall radiotherapy. Radiat Oncol. 2024. PMID: 39558366. doi:10.1186/s13014-024-02552-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。